BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24792977)

  • 1. Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
    Adebisi AO; Conway BR
    Int J Pharm; 2014 Aug; 470(1-2):28-40. PubMed ID: 24792977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori.
    Jain SK; Jangdey MS
    Mol Pharm; 2009; 6(1):295-304. PubMed ID: 19093870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
    Rajinikanth PS; Karunagaran LN; Balasubramaniam J; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1658-64. PubMed ID: 19043235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.
    Fernandes M; Gonçalves IC; Nardecchia S; Amaral IF; Barbosa MA; Martins MC
    Int J Pharm; 2013 Sep; 454(1):116-24. PubMed ID: 23850814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of floating mucoadhesive alginate beads for targeting Helicobacter pylori.
    Adebisi AO; Laity PR; Conway BR
    J Pharm Pharmacol; 2015 Apr; 67(4):511-24. PubMed ID: 25496042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-Conjugated Clarithromycin and Acetohydroxamic Acid-Loaded PLGA Nanoparticles: a Novel Approach for Effective Treatment of H. pylori.
    Jain SK; Haider T; Kumar A; Jain A
    AAPS PharmSciTech; 2016 Oct; 17(5):1131-40. PubMed ID: 26566630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
    Patel JK; Patel MM
    Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK; Chavda JR
    J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach.
    Majithiya RJ; Murthy RS
    Curr Drug Deliv; 2005 Jul; 2(3):235-42. PubMed ID: 16305425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin.
    Sahasathian T; Praphairaksit N; Muangsin N
    Arch Pharm Res; 2010 Jun; 33(6):889-99. PubMed ID: 20607494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoadhesive gastroretentive microparticulate system for programmed delivery of famotidine and clarithromycin.
    Srivastava A; Verma A; Saraf S; Jain A; Tiwari A; Panda PK; Jain SK
    J Microencapsul; 2021 May; 38(3):151-163. PubMed ID: 33205689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate.
    Anande NM; Jain SK; Jain NK
    Int J Pharm; 2008 Jul; 359(1-2):182-9. PubMed ID: 18486369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pH triggers in situ porous controlled release micro balloon delivery of amoxicillin for eradication of Helicobacter pylori.
    Tripathi GK; Singh S; Nath G; Dubey RK
    Curr Drug Deliv; 2011 Nov; 8(6):667-77. PubMed ID: 22313162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.
    Wang J; Tauchi Y; Deguchi Y; Morimoto K; Tabata Y; Ikada Y
    Drug Deliv; 2000; 7(4):237-43. PubMed ID: 11195431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of novel multi-core chitosan microspheres for stomach-specific delivery of hydrophilic antibiotics.
    Zhu X; Zhou D; Guan S; Zhang P; Zhang Z; Huang Y
    J Mater Sci Mater Med; 2012 Apr; 23(4):983-90. PubMed ID: 22322786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel microsphere with a three-layer structure for duodenum-specific drug delivery.
    Zhu X; Zhou D; Jin Y; Song YP; Zhang ZR; Huang Y
    Int J Pharm; 2011 Jul; 413(1-2):110-8. PubMed ID: 21536116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori.
    Chun MK; Sah H; Choi HK
    Int J Pharm; 2005 Jun; 297(1-2):172-9. PubMed ID: 15907604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
    Gonçalves IC; Henriques PC; Seabra CL; Martins MC
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori.
    Pan-In P; Banlunara W; Chaichanawongsaroj N; Wanichwecharungruang S
    Carbohydr Polym; 2014 Aug; 109():22-7. PubMed ID: 24815396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.